Critical appraisal of sorafenib in the treatment of Chinese patients with renal cell carcinoma
Ding-Wei Ye, Hai-Liang Zhang 1Department of Urology, Fudan University Shanghai Cancer Center, 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China Abstract: Renal cell carcinoma (RCC) accounts for 3% of all malignancies, and is the most...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-06-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/critical-appraisal-of-sorafenib-in-the-treatment-of-chinese-patients-w-a17138 |